Diagnosis of Trypanosoma cruzi chronic infections in humans: usefulness of the complement regulatory protein antigens and lytic antibodies in the control of cure.
Krettli
A
A
Centro de Pesquisas René Rachou, Fiocruz, Belo Horizonte, MG, 30190-002, Brasil. akrettli@netra.cpqrr.fiocruz.br
D000818:Animals; D000913:Antibodies, Protozoan / Q000032:analysis*; D000953:Antigens, Protozoan / Q000032:analysis*; D014355:Chagas Disease / Q000175:diagnosis* / Q000276:immunology / Q000628:therapy; D002908:Chronic Disease; D006801:Humans; D008562:Membrane Glycoproteins / Q000032:analysis*; D051379:Mice; D015800:Protozoan Proteins / Q000032:analysis*; D012680:Sensitivity and Specificity; D020525:Xenodiagnosis
D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D008562:Membrane Glycoproteins; D015800:Protozoan Proteins; C103951:complement regulatory protein, Trypanosoma cruzi